Sharplink Inc
6 nominees · 2 ballot items.
Special Meeting proposals: (1) to increase authorized common shares; (2) to approve Amended and Restated 2023 Equity Incentive Plan, which would add 8,000,000 shares, with the Board recommending 'FOR' on both.
Follow how the vote landed and what changed on Sharplink Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot2
- 1
Approval of an Amendment to Our Amended and Restated Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock of the Company
ManagementBoard: FORIncrease the authorized common stock from 100,000,000 to 500,000,000 shares and related effects; board believes this provides flexibility for future capital needs, the Ethereum Treasury Strategy, future financings, acquisitions, and incentive plans.
- 2
Approval of the Amended and Restated SharpLink Gaming, Inc. 2023 Equity Incentive Plan
ManagementBoard: FORAmended plan to increase the share reserve by 8,000,000 shares, enable additional equity awards, and implement plan governance and new plan benefits; if not approved, awards may be cancelled; plan will be effective on the Special Meeting date; outlines 8,000,000 shares, overhang, dilution; includes new governance features like no repricing without etc.
Nominees on the ballot6
Top institutional holders7
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | PrairieView Partners, LLC | 28.0% | 66,759 | $107K |
| 2 | MORGAN STANLEY | 4.0% | 9,624 | $15K |
| 3 | JPMORGAN CHASE CO | 0.1% | 310 | $493 |
| 4 | Tower Research Capital LLC (TRC | 0.1% | 300 | $480 |
| 5 | UBS Group AG | 0.0% | 25 | $40 |
| 6 | TUCKER ASSET MANAGEMENT LLC | 0.0% | 10 | $16 |
| 7 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0.0% | — | $0 |
Other Financial Services sector meetings6
Upcoming shareholder meetings at Sharplink Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Sharplink Inc 2025 special meeting?
- Sharplink Inc (SBET) holds its 2025 special shareholder meeting on Thursday, July 24, 2025.
- What is the record date for the Sharplink Inc 2025 meeting?
- The record date for the Sharplink Inc 2025 meeting is Wednesday, June 18, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Sharplink Inc's 2025 meeting?
- The board is presenting 6 director nominees at the Sharplink Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Sharplink Inc 2025 meeting?
- Shareholders will vote on 2 proposals at the Sharplink Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.